{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:25:57Z","timestamp":1788531957628,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Academic Research Projects of Southwest Medical University","award":["2023QN042"],"award-info":[{"award-number":["2023QN042"]}]},{"name":"Luzhou Municipal Government\u2014Southwest Medical University Cooperation Application Foundation","award":["2023LZXNYDJ045"],"award-info":[{"award-number":["2023LZXNYDJ045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01561-x","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T11:15:33Z","timestamp":1736853333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decreased STING predicts adverse efficacy in bortezomib regimens and poor survival in multiple myeloma"],"prefix":"10.1007","volume":"25","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"1561_CR1","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","volume":"3","author":"SK Kumar","year":"2017","unstructured":"Kumar SK, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046.","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"1561_CR2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2174\/1568009617666170214102301","volume":"17","author":"Y Kawano","year":"2017","unstructured":"Kawano Y, et al. Multiple myeloma and the immune microenvironment. Curr Cancer Drug Targets. 2017;17(9):806\u201318.","journal-title":"Curr Cancer Drug Targets"},{"issue":"7","key":"1561_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/0192623317735316","volume":"45","author":"MN Weitzmann","year":"2017","unstructured":"Weitzmann MN. Bone and the immune system. Toxicol Pathol. 2017;45(7):911\u201324.","journal-title":"Toxicol Pathol"},{"issue":"25","key":"1561_CR4","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.7150\/thno.37574","volume":"9","author":"T Su","year":"2019","unstructured":"Su T, et al. STING activation in cancer immunotherapy. Theranostics. 2019;9(25):7759\u201371.","journal-title":"Theranostics"},{"key":"1561_CR5","doi-asserted-by":"publisher","first-page":"39858","DOI":"10.1038\/srep39858","volume":"7","author":"S Song","year":"2017","unstructured":"Song S, et al. Decreased expression of STING predicts poor prognosis in patients with gastric cancer. Sci Rep. 2017;7:39858.","journal-title":"Sci Rep"},{"issue":"11","key":"1561_CR6","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1038\/s41418-019-0302-0","volume":"26","author":"CX Zhang","year":"2019","unstructured":"Zhang CX, et al. STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion. Cell Death Differ. 2019;26(11):2314\u201328.","journal-title":"Cell Death Differ"},{"issue":"5","key":"1561_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jtho.2020.01.009","volume":"15","author":"CC Della","year":"2020","unstructured":"Della CC, et al. STING pathway expression identifies NSCLC with an immune-responsive phenotype. J Thorac Oncol. 2020;15(5):777\u201391.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"1561_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/art.39863","volume":"69","author":"R Baum","year":"2017","unstructured":"Baum R, et al. STING contributes to abnormal bone formation induced by deficiency of DNase II in mice. Arthritis Rheumatol. 2017;69(2):460\u201371.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"1561_CR9","doi-asserted-by":"publisher","first-page":"e21964","DOI":"10.1096\/fj.202100069RR","volume":"35","author":"X Chen","year":"2021","unstructured":"Chen X, et al. STING inhibition accelerates the bone healing process while enhancing type H vessel formation. FASEB J. 2021;35(11):e21964.","journal-title":"FASEB J"},{"issue":"8","key":"1561_CR10","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1158\/0008-5472.CAN-15-1885","volume":"76","author":"CH Tang","year":"2016","unstructured":"Tang CH, et al. Agonist-mediated activation of STING induces apoptosis in malignant B cells. Cancer Res. 2016;76(8):2137\u201352.","journal-title":"Cancer Res"},{"issue":"5","key":"1561_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1158\/2643-3230.BCD-21-0047","volume":"2","author":"A Gulla","year":"2021","unstructured":"Gulla A, et al. Bortezomib induces anti-multiple myeloma immune response mediated by cGAS\/STING pathway activation. Blood Cancer Discov. 2021;2(5):468\u201383.","journal-title":"Blood Cancer Discov"},{"key":"1561_CR12","doi-asserted-by":"publisher","first-page":"599532","DOI":"10.3389\/fonc.2021.599532","volume":"11","author":"DVSJ Garcia","year":"2021","unstructured":"Garcia DVSJ, et al. HLC pair suppression as a risk factor for bacterial bloodstream infections and early mortality in newly diagnosed intact immunoglobulin multiple myeloma patients. Front Oncol. 2021;11:599532.","journal-title":"Front Oncol"},{"issue":"3","key":"1561_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hon.2323","volume":"34","author":"V Friman","year":"2016","unstructured":"Friman V, et al. Secondary immunodeficiency in lymphoproliferative malignancies. Hematol Oncol. 2016;34(3):121\u201332.","journal-title":"Hematol Oncol"},{"issue":"3","key":"1561_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41409-018-0264-8","volume":"54","author":"WI Gonsalves","year":"2019","unstructured":"Gonsalves WI, et al. Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus statement. Bone Marrow Transpl. 2019;54(3):353\u201367.","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"1561_CR15","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1016\/S2352-3026(18)30220-5","volume":"6","author":"G Cook","year":"2019","unstructured":"Cook G, et al. A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK myeloma research alliance risk profile): a development and validation study. Lancet Haematol. 2019;6(3):e154\u201366.","journal-title":"Lancet Haematol"},{"issue":"3","key":"1561_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0926-6593(65)80213-2","volume":"99","author":"M Zatti","year":"1965","unstructured":"Zatti M, Rossi F. Early changes of hexose monophosphate pathway activity and of NADPH oxidation in phagocytizing leucocytes. Biochim Biophys Acta. 1965;99(3):557\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"1561_CR17","doi-asserted-by":"publisher","first-page":"102305","DOI":"10.1016\/j.redox.2022.102305","volume":"52","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury. Redox Biol. 2022;52:102305.","journal-title":"Redox Biol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01561-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01561-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01561-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:52:16Z","timestamp":1764917536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01561-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01561-x","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Southwest Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"37"}}